Solen Prime

Title: Solen Prime: Innovator in Tobacco-Specific Nitrosamine Reduction

Introduction

Solen Prime is a notable inventor based in Le Mans, France. He has made significant contributions to the field of tobacco research, particularly in reducing harmful substances found in tobacco products. His innovative approach has the potential to improve public health by addressing the dangers associated with tobacco consumption.

Latest Patents

Solen Prime holds a patent for a method of reducing tobacco-specific nitrosamines (TSNAs). This method involves combining tobacco with a solvent to create a soluble extracts fraction and an insoluble residue fraction. The soluble extracts fraction is then treated with a nitrosamine-reducing material, which may include sepiolite, to lower the levels of TSNAs. Additionally, the insoluble residue fraction is treated with an alkali extractant, such as a hydroxide, to further reduce TSNAs. The final product is a reconstituted tobacco product that can achieve a reduction of TSNAs by at least 30%, and potentially up to 50%.

Career Highlights

Throughout his career, Solen Prime has focused on innovative solutions to complex problems in the tobacco industry. His work has garnered attention for its potential to create safer tobacco products. With a patent portfolio that includes this significant innovation, he continues to contribute to advancements in tobacco research.

Collaborations

Solen Prime has collaborated with notable colleagues, including Safall Fall and Nathalie Durot. Their combined expertise has fostered a productive environment for research and development in the field of tobacco safety.

Conclusion

Solen Prime's work in reducing tobacco-specific nitrosamines represents a crucial step towards safer tobacco products. His innovative methods and collaborations highlight the importance of research in improving public health outcomes.